Common Equity: The sum of all common equity items.
Eli Lilly and Company (LLY) had Common Equity of $26.54B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$19.29B |
|
$6.64B |
|
$3.37B |
|
$15.92B |
|
$10.92B |
|
$8.37B |
|
$-108.30M |
|
$8.27B |
|
$8.27B |
|
$6.64B |
|
$6.64B |
|
$6.64B |
|
$6.64B |
|
$8.37B |
|
$8.96B |
|
897.30M |
|
899.30M |
|
$7.41 |
|
$7.39 |
|
| Balance Sheet Financials | |
$55.63B |
|
$24.68B |
|
$56.85B |
|
$112.48B |
|
$35.23B |
|
$40.87B |
|
$50.71B |
|
$85.94B |
|
|
Common Equity |
$26.54B |
$14.12B |
|
$26.54B |
|
944.80M |
|
| Cash Flow Statement Financials | |
$16.81B |
|
$-10.97B |
|
$-2.21B |
|
$3.27B |
|
$7.27B |
|
$4.00B |
|
$626.00M |
|
$-5.38B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.58 |
|
-- |
|
-- |
|
0.61 |
|
1.60 |
|
82.52% |
|
43.41% |
|
43.41% |
|
-- |
|
42.85% |
|
34.41% |
|
$8.97B |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.25 |
|
0.96 |
|
94.03 |
|
25.01% |
|
47.02% |
|
5.90% |
|
9.85% |
|
$28.09 |
|
$9.98 |
|
$18.70 |
|